Vaccines Don’t Shield Against Long COVID, But May Ease Symptoms
5:52 PM CDT.
By Dennis Thompson HealthDay Reporter Read article
- U.S. Doctors Already Face Big Hurdles Accessing Abortion Pill
- AHA News: Asian and Pacific Islander Adults Less Likely to Get Mental Health Services Despite Growing Need
- Most COVID Long-Haulers Still Having Symptoms 15 Months Later
- Limiting TV to Under 1 Hour a Day Could Slash Heart Disease Rates: Study
JOURNAL UPDATE
Post-COVID Conditions Are Common Among Adult Survivors
9:36 PM CDT.More than twofold risk of acute pulmonary embolism and respiratory signs and symptoms among survivors…
- Suicide by Firearm Down Globally From 1990 to 2019
- Gout Drug May Cut Mortality in Heart Failure Hospitalizations
- Impact of Policy Changes for Anemia Care in Hemodialysis Examined
MONTHLY JOURNAL SUMMARY
September 2020 Briefing - Pharmacy
October 01, 2020. The Monthly Journal Summary is a single article covering the most important journal articles published in the previous 30 days.
FEATURED ARTICLES
Immunotherapy with Checkpoint Inhibitors in Triple Negative Breast Cancer (TNBC)
Karima Oualla, MD.
Dr. Karima Oualla discusses recent advances on the use of checkpoint inhibitors in the treatment of triple negative breast cancer (TNBC). Dr. Oualla is an International expert in breast cancer and is the primary author of the manuscript entitled "Novel therapeutic strategies in the treatment of triple-negative…
Rucaparib Maintenance Therapy Improves PFS in Platinum-sensitive Ovarian Cancer - The ARIEL3 Trial
Robert L. Coleman, MD.
Professor Robert L. Coleman M.D., FACOG, FACS discusses the implications of data from the Phase 3 ARIEL3 trial of the novel PARP inhibitor rucaparib as maintenance therapy in patients with platinum-sensitive ovarian cancer. Professor Coleman is the Vice Chair of Clinical Research in the Department of…
Investigational Topical Minocycline Gel for Acne Advances to Phase III Development
Ted Lain, MD.
Clinical trial investigator Dr. Ted Lain comments on the results of the OPAL study, a Phase 2b clinical trial which evaluated the efficacy of a novel topical gel formulation of the antibiotic minocycline (BPX-01) in reducing the number of inflammatory lesions in patients with moderate-to-severe inflammatory,…
MEDICAL FOCUS
Acute dyspnea (shortness of breath)
By Tamer M. Fouad, M.D.Dyspnea (shortness of breath) is a term used to characterize a subjective experience of breathing discomfort that is comprised of qualitatively distinct…
DISCUSSION
RE: Investigational Topical Minocycline Gel for Acne Advances to Phase III Development
By namabcAs I understand, this is a great step of development that we can use to save many people from horrible diseases. and i also hope Dr.Lain and your partners…
ANNOUNCEMENTS
Sunday Times - Doctors Lounge Voted top 10 best ‘Ask an expert’ website
Times Online / The Sunday Times voted Doctors Lounge as 3rd best ‘Ask an expert’ website.
